Search
Mild Dementia due to Parkinson's disease
go.drugbank.com/conditions/DBCOND0025346Drugs: RivastigmineSynonyms: Mild Dementia due to Parkinson's diseaseFremanezumab
go.drugbank.com/drugs/DB14041ApprovedInvestigationalFremanezumab is a humanized monoclonal antibody targeted against human calcitonin gene-related peptide (CGRP) for the prevention of migraine headaches. … [L11749] It was developed by Teva Pharmaceuticals USA and approved by the FDA in September 2018.
Products: AJOVY SOLUTION FOR INJECTION IN PRE-FILLED PEN 225 MG/1.5ML, AJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225 MG/1.5MLClobetasol propionate
go.drugbank.com/drugs/DB01013ApprovedInvestigationalClobetasol propionate is a prednisolone derivative with higher specificity for glucocorticoid receptors than mineralocorticoid receptors. … [L11815] It has demonstrated superior activity compared to [fluocinonide][A190963] and was first described in the literature in 1974.
Products: KARISON SALBE, CLOBEGALEN SALBEInterferon beta-1a
go.drugbank.com/drugs/DB00060ApprovedInvestigationalThe amino acid sequence is identical to that of natural human interferon beta. … It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced.
Products: Rebif 22mcg/0.5ml solution for injection, Rebif 44mcg/0.5ml solution for injectionGadoteric acid
go.drugbank.com/drugs/DB09132ApprovedInvestigationalGadoteric acid, commonly used in the salt form gadoterate meglumine, is a macrocyclic, ionic gadolinium-based contrast agent (GBCA). … [A263141,A263106] Gadoterate is approved by the FDA under the brand name DOTAREM on 20th March 2013 for intravenous uses with magnetic resonance imaging (MRI) in the brain (intracranial), spine, and
Categories: Compounds used in a research, industrial, or household settingProducts: DOTAGRAF SOLUTION FOR INJECTION 0.5 MMOL/ML, CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/MLLiraglutide
go.drugbank.com/drugs/DB06655ApprovedInvestigational[Label,A6932] Liraglutide is 97% similar to native human GLP-1, differing primarily by substituting arginine for lysine at position 34. … [A6932] Liraglutide is made by attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide precursor.
Products: solution for injection in pre-filled pen 6mg/ml, SOLUTION FOR INJECTION IN PRE-FILLED PEN 6MG/MLAcetaminophen
go.drugbank.com/drugs/DB00316ApprovedInvestigational[A176318] It is also used for its antipyretic effects, helping to reduce fever.[F4124] This drug was initially approved by the U.S. … [L5783] Confusion about dosing of this drug may be caused by the availability of different formulas, strengths, and dosage instructions for children of different ages.
Mixtures: ASIST COLD C 600 MG/600 MG/300 MG TOZ IÇEREN SAŞE,20 SAŞE, ASIST COLD C 600 MG/600 MG/300 MG TOZ IÇEREN SAŞE,30 SAŞEInternational brands: Snaplets-FRPhenylephrine
go.drugbank.com/drugs/DB00388ApprovedInvestigationalPhenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension,[L9416,L9410] dilate the pupil,[L9413] and induce local vasoconstriction. … [A187370] The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.[A187376] Phenylephrine was granted FDA approval in 1939.[L9413]
Mixtures: DAYCOLD-HOT 500/10/15/100 MG SAŞE,6 SAŞE, DAYCOLD-HOT 500/10/15/100 MG SAŞE ,10 SAŞECategories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Nasal Decongestants for Systemic UseTremelimumab
go.drugbank.com/drugs/DB11771ApprovedInvestigationalCTLA-4 is a cell surface receptor expressed on activated T cells to act as a negative regulator for T cells. … [A253717] By binding to CTLA-4, tremelimumab enhances T cell-mediated killing of tumours and reduces tumour growth.
Products: Imjudo Concentrate for Solution for Intravenous Infusion 20 mg/mLTeriparatide
go.drugbank.com/drugs/DB06285ApprovedInvestigationalTeriparatide is a recombinant parathyroid hormone (PTH) analog and a potent osteoanabolic agent. It is made up of the first amino(N)-terminal 34 amino acids of the human PTH. First approved in the United States in November 2002 and in Eu...
Products: FORTEO 250 UG SOLUTION FOR INJECTION, KAULIV 20 micrograms/80 microliters solution for injection